FDA Approved: SPINRAZA — Supplemental Application (Biogen Inc.)

View source ↗

Summary

FDA approved a supplemental application for Spinraza (nusinersen) submitted by Biogen. This action updates the drug's labeling and may expand its indicated use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Spinraza (nusinersen)

Snippet

SUPPL AP for SPINRAZA (NUSINERSEN)